DavidRogerDeyleMD
Medical Genetics • Rochester, MNClinical Genetics
Assistant Professor, Medical Genetics, Mayo Medical School
Are you Dr. Deyle?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 27 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
200 1st St Sw
Rochester, MN 55905Phone+1 507-284-2511
Summary
- Dr. David Deyle, MD is a board certified medical geneticist in Rochester, Minnesota. He is currently licensed to practice medicine in Minnesota, Arizona, and Florida. He is affiliated with Mayo Clinic Hospital - Rochester and is an Assistant Professor at Mayo Medical School.
Education & Training
University of WashingtonResidency, Medical Genetics and Genomics, 2004 - 2006
University of MinnesotaResidency, Internal Medicine/Pediatrics, 2000 - 2004- University of Minnesota Medical SchoolClass of 2000
Certifications & Licensure
MN State Medical License 2012 - 2025
AZ State Medical License 2016 - 2022
FL State Medical License 2016 - 2020
WA State Medical License 2004 - 2013- American Board of Medical Genetics and Genomics Clinical Genetics and Genomics
Publications & Presentations
PubMed
- 12 citationsTRAPPC9-CDG: A novel congenital disorder of glycosylation with dysmorphic features and intellectual disability.Silvia Radenkovic, Diego Martinelli, Yuebo Zhang, Graeme J Preston, Arianna Maiorana
Genetics in Medicine. 2022-04-01 - 2 citationsEarly and Late Outcomes of Cardiovascular Surgery in Patients With Ehlers-Danlos Syndrome.Mohamed F. Elsisy, Alberto Pochettino, Joseph A. Dearani, Thomas C. Bower, Robert D. McBane
World Journal for Pediatric & Congenital Heart Surgery. 2021-11-01 - 1 citationsThree Patient Kindred with a Novel Phenotype of Osteogenesis Imperfecta due to a COL1A1 VariantNidhi Gupta, Seth W. Gregory, David R. Deyle, Peter J. Tebben
Journal of Clinical Research in Pediatric Endocrinology. 2021-06-01
Press Mentions
Castle Creek Biosciences Expands Its Innovative Gene Therapy Platform for Rare Genetic Connective Tissue Disorders Through Research Collaboration with Mayo ClinicSeptember 29th, 2021- Research Grants Aim to Advance Regenerative Medicine Toward the PracticeJune 29th, 2020
Recombinetics Announces Collaboration with Mayo Clinic to Develop the First-Ever Swine Models of Osteogenesis ImperfectaOctober 7th, 2019- Join now to see all
Grant Support
- Gene Targeting With AAV Vectors For The Treatment Of Osteogenesis ImperfectaNational Institute Of Arthritis And Musculoskeletal And Skin Diseases2008–2011
